---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-027568"
form_type: "8-K"
ticker: "GTBP"
cik: "0000109657"
company_name: "GT Biopharma, Inc."
filed_at: "2022-10-04T23:59:59+00:00"
generated_at: "2026-06-23T05:30:03.353612+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# GT Biopharma adjourns special shareholders meeting due to lack of quorum; reconvened Oct 10

## Summary
- Special meeting on Sept 28 lacked quorum; adjourned to Oct 10, 2022 at 11 a.m. PST.
- Record date remains Aug 8, 2022; prior votes count unless changed.
- Proposal unchanged: ratify discretionary broker voting on authorized share reduction from 750M to 250M.
- Company urges all shareholders to vote by Oct 9 to ensure quorum at reconvened meeting.

## SEC filing metadata
- accession: 0001493152-22-027568
- form_type: 8-K
- ticker: GTBP
- cik: 0000109657
- company_name: GT Biopharma, Inc.
- filed_at: 2022-10-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/109657/000149315222027568/0001493152-22-027568-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/109657/000149315222027568/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-027568
- JSON: https://secwatch.observer/filing/0001493152-22-027568.json
- Plain text: https://secwatch.observer/filing/0001493152-22-027568.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.